首页> 外文会议>American Peptide Symposium >Efficient Total Synthesis of Dipeptidic Antibiotics (+)-Negamycin and Its Derivatives
【24h】

Efficient Total Synthesis of Dipeptidic Antibiotics (+)-Negamycin and Its Derivatives

机译:高效合成二肽抗生素(+) - 尼蛋白和其衍生物

获取原文

摘要

(+)-Negamycin 1 [1], a dipeptidic antibiotic containing a hydrazine peptide bond is recently thought to be a potential therapeutic agent for genetic diseases such as Duchenne muscular dystrophy (DMD) with a nonsense mutation in the dystrophin gene [2]. Negamycin has attracted a great deal of synthetic interest. Several syntheses of negamycin in both racemic and optically active forms have been accomplished over three decades after its discovery. However, an efficient shortened synthetic route of (+)-l and its derivatives appears significant to develop promising new therapeutic candidates for DMD and other diseases caused by nonsense mutations. In the previous study, we developed a new synthetic route to obtain (+)-l from (R)ethyl-4-chloro-3-hydroxybutanoate in 26% overall yield over 13 steps [3]. Here, we report another attractive synthetic route for (+)-l from commercially available achiral Boc-glycinal 2 using modern organic chemistry techniques, including asymmetric allylboration, microwave-assisted ruthenium catalyzed cross-metathesis and asymmetric Michael addition to afford (+)-l with an overall yield 41% in 8 steps [4].
机译:(+) - 乙酰胺1 [1],含有肼肽键的二肽抗生素最近被认为是遗传疾病的潜在治疗剂,例如Dystophin基因中具有非本文突变的遗传疾病(DMD)[2]。尼胺霉素吸引了大量的综合兴趣。在发现后三十年来,在外消旋和光学活跃的形式中的几个合成的尼蛋白酶已经完成了。然而,(+) - L及其衍生物的有效缩短的合成途径似乎很大,为DMD和由非礼突变引起的其他疾病发出了对新的治疗性候选者。在先前的研究中,我们开发了一种新的合成途径,从(+) - 4-氯-3-羟基苯甲酸盐中获得26%的总产量超过13步[3]。在这里,我们通过现代有机化学技术报告了来自市售的成立Boc-glycinal 2的另一个有吸引力的合成途径,包括不对称的烯丙基硼酸化,微波辅助钌催化的交叉复分解和不对称迈克尔(+) - l总体产量为41%,8步[4]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号